Health Aug 18, 2025

Ketamine use in chronic pain unsupported by evidence, review finds

The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found...

Market Touch Signal is a free discovery window from Oy Market Touch Ltd. Practical intelligence, clear communication and useful digital ventures: https://market-touch.org/

Related News

View All

Business May 28, 2026

Oscar-winning actress Hel...

Business May 28, 2026

FSSAI pulls up IRCTC over...

Business May 28, 2026

Maine Engineer with H-1B ...

Business May 28, 2026

Even the Ronald Reagan In...

Business May 28, 2026

Lilly’s GLP-1 medicatio...

Business May 28, 2026

Anthropic nears $1 trilli...

Business May 28, 2026

The new bipartisan colleg...

Business May 28, 2026

Oil prices show mixed rea...

Trending News

Business Mar 02, 2026

US-Iran conflict: No comm...

Business Mar 02, 2026

Kuwait mistakenly shot do...

Business Mar 02, 2026

India and Canada launch C...

Business Mar 02, 2026

Trump says US is 'knockin...

Business Mar 02, 2026

US aircraft leave Spain a...

Business Mar 02, 2026

Top US general: will take...

Business Mar 02, 2026

Rising oil prices and fre...

Trending

Ketamine use in chronic pain unsupported by evidence, review finds

Related News

Trending News

Tags

Get In Touch

Follow Us

Popular News

Categories

Flickr Photos